CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform Powered by Machine Learning prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Joint Study Shows Decentralized Clinical Trials More Resilient than Traditional Trials During Global Pandemic
THREAD-Supported DCTs Outperform Industry Benchmark in Patient Recruitment and Retention
News provided by
Share this article
CARY, N.C.
and NEW YORK, Feb. 11, 2021 /PRNewswire/ THREAD, a global decentralized clinical trials (DCTs) and eCOA provider, and Lokavant, a leading clinical trial intelligence company, today announced the results of a joint analysis demonstrating that clinical trials using decentralized approaches during the COVID-19 pandemic outperformed traditional trials in patient recruitment and retention levels.
The study shows patient recruitment and retention dropped across the industry in early 2020 due to global quarantines and stay-at-home orders. However, decentralized trials rapidly returned to pre-pandemic recruitment and retention levels while traditionally designed clinical trials had yet to recover through September 2020.